CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
6 hedge funds and large institutions have $10.5M invested in Celyad Oncology SA American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$603K |
| 2 |
Morgan Stanley
New York
|
+$14.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.29K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$252 |
Top Sellers
| 1 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$238K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $9.99M | +$603K | +22,600 | +6% |
|
|
DCM
2
DAFNA Capital Management
Los Angeles,
California
| $328K | – | – | – |
|
|
3
Morgan Stanley
New York
| $83K | +$14.8K | +562 | +22% |
|
|
4
Zurich Cantonal Bank
Zurich,
Switzerland
| $42K | -$238K | -8,833 | -85% |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | +$9.29K | +347 | +542% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $9K | +$252 | +10 | +3% |
|